Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
Mapk9
REST API REST API
Mus musculus
Mapk9 is differentially expressed in 224 experiments: 116 organism parts: liver, hippocampus, ... (114 more);, 16 disease states: normal, GM-CSF tumor-bearing, ... (14 more);, 79 cell types 15 cell lines 46 compound treatments and 41 other conditions.
Synonyms 'Prkm9', 'JNK/SAPK alpha', 'JNK2'
Orthologs HOG1 (Saccharomyces cerevisiae)   Q4H3A2_CIOIN (Ciona intestinalis)   Q2KI72_BOVIN (Bos taurus)   Mapk9 (Rattus norvegicus)   MAPK9 (Homo sapiens)   MK09_CHICK (Gallus gallus)   (Compare orthologs)
Gene Ontology Term cytosol, regulation of JNK cascade, phosphorylation, positive regulation of caspase activity, JUN kinase activity, positive regulation of nitric oxide biosynthetic process, protein binding, phosphotransferase activity, alcohol group as acceptor, JUN phosphorylation, cytoplasm, positive regulation of gene expression, membrane, activation of caspase activity, protein tyrosine kinase activity, MAP kinase activity, positive regulation of apoptosis, transcription factor binding, response to cadmium ion, ATP binding, transferase activity, transferring phosphorus-containing groups, neuron projection development, nucleus, caspase activator activity, nucleotide binding, kinase activity, protein serine/threonine kinase activity, response to drug, JNK cascade, transferase activity, regulation of protein ubiquitination, positive regulation of transcription, DNA-dependent, lipopolysaccharide biosynthetic process, protein kinase activity, mitochondrion, positive regulation of prostaglandin secretion, positive regulation of macrophage derived foam cell differentiation, positive regulation of cell morphogenesis involved in differentiation, release of cytochrome c from mitochondria, cellular response to UV, cytosolic part, positive regulation of prostaglandin biosynthetic process, induction of apoptosis in response to chemical stimulus, positive regulation of chemokine production, mitogen-activated protein kinase kinase kinase binding, positive regulation of nitric-oxide synthase biosynthetic process, protein phosphorylation, positive regulation of protein phosphorylation
InterPro Term Prot_kinase_cat_dom, JNK_MAPK, LipoPS_kinase, Ser/Thr_kinase_dom, Tyr_kinase_cat_dom, Ser-Thr/Tyr_kinase, Se/Thr_kinase-like_dom
Search EB-eye ENSMUSG00000020366
Show more properties
Experimental Factors
Organism part

studied in E-TABM-1039, E-GEOD-1479, E-GEOD-2866, E-MEXP-1636, E-JJRD-1, ... (53 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-MEXP-1689, E-GEOD-21515, E-GEOD-1956, E-MEXP-2554, E-GEOD-18322, ... (6 experiments)

Factor Value U/D Experiments
IP20D-3
1
E-GEOD-21515
B117H
2
1
E-GEOD-18322
RAW264
1
E-MEXP-2554
IP36D-3
1
E-GEOD-21515
R10
1
E-MEXP-1689
4T1
1
E-GEOD-11259
9 more value(s).


Cell type

studied in E-GEOD-19401, E-GEOD-7764, E-GEOD-7069, E-GEOD-1584, E-GEOD-5309, ... (24 experiments)

Factor Value U/D Experiments
erythroid progenitor
1
E-GEOD-1584
universal mouse reference RNA
1
E-GEOD-5309
lateral motoneuron
1
E-GEOD-2595
in vitro pLN follicular dendritic cell
1
E-GEOD-19401
ex vivo pLN follicular dendritic cell
1
E-GEOD-19401
dermal papilla
1
E-GEOD-3142
73 more value(s).


Disease state

studied in E-GEOD-21927, E-GEOD-19004, E-GEOD-642, E-GEOD-21902, E-MEXP-1137, ... (10 experiments)

Factor Value U/D Experiments
hepatocellular carcinoma
1
E-GEOD-19004
MMTV-Myc
1
1
E-GEOD-15904
type 2 diabetes
1
E-GEOD-642
bronchoalveolar adenocarcinoma
1
1
E-MEXP-1137
LPS-induced acute lung injury
1
1
E-GEOD-1871
myocardial infarction
1
E-GEOD-775
10 more value(s).


Compound treatment

studied in E-GEOD-19684, E-TABM-903, E-GEOD-1301, E-GEOD-4671, E-TABM-310, ... (29 experiments)

Factor Value U/D Experiments
none
4
9
E-GEOD-2973, E-GEOD-5304, E-MEXP-1702, E-MEXP-703, E-TABM-363, ... (13 experiments)
lipopolysaccharide
1
2
E-GEOD-2411, E-TABM-310, E-GEOD-10246
DDA-MPL
1
E-MEXP-1814
dexamethasone and doxycycline
1
E-TABM-675
HDM allergen
1
E-GEOD-1301
N-(1-naphthyl)ethylenediamine dihydrochloride
1
E-GEOD-5128
40 more value(s).


Agent

studied in E-GEOD-32706

Factor Value U/D Experiments
fenofibrate
1
1
E-GEOD-32706
control
1
E-GEOD-32706


Amount to core
studied in E-GEOD-18858

Clinical info
studied in E-GEOD-1800

Clinical treatment
studied in E-GEOD-2411

Cohort
studied in E-GEOD-20524

Developmental stage
studied in E-GEOD-5668, E-GEOD-1026, E-GEOD-1479, E-GEOD-16533, E-GEOD-4870, ... (22 experiments)

dose or concentration
studied in E-GEOD-18858

Environmental stress
studied in E-GEOD-3486

Fraction
studied in E-TABM-363

Genetic modification
studied in E-GEOD-3172

Genotype
studied in E-GEOD-19684, E-GEOD-19004, E-MEXP-1649, E-TABM-285, E-GEOD-19194, ... (35 experiments)

Growth condition
studied in E-GEOD-495

Histology
studied in E-GEOD-15904

in vivo treatment
studied in E-GEOD-18858

Infection
studied in E-MEXP-1190, E-GEOD-17049, E-GEOD-4324, E-MEXP-1717, E-MEXP-1942, ... (6 experiments)

infection duration (days)
studied in E-GEOD-20524

infection status
studied in E-GEOD-20524

Injury
studied in E-GEOD-1999, E-GEOD-5296

Light
studied in E-TABM-285

Media
studied in E-MEXP-718

Observation
studied in E-GEOD-3594, E-GEOD-5296

Od260
studied in E-GEOD-18858

Organism
studied in E-MEXP-667

Organism status
studied in E-GEOD-22125

Phenotype
studied in E-GEOD-272

Protocol type
studied in E-GEOD-12293, E-GEOD-21389

Ratio
studied in E-GEOD-18858

Replicate
studied in E-GEOD-17112

Rna integrity number
studied in E-GEOD-18858

RNAi
studied in E-MEXP-1342

sample preservation
studied in E-GEOD-18858

Sampling time point
studied in E-GEOD-22125

Sex
studied in E-GEOD-97, E-MEXP-1711, E-GEOD-3530

Stimulus or stress
studied in E-GEOD-15894, E-GEOD-15902

Strain or line
studied in E-GEOD-17936, E-GEOD-5429, E-GEOD-21927, E-GEOD-3100, E-TABM-671, ... (12 experiments)

Treatment
studied in E-MTAB-76, E-GEOD-21902, E-GEOD-18344, E-GEOD-22009, E-GEOD-21841, ... (11 experiments)

Treatment repeat
studied in E-GEOD-18858

Treatment time
studied in E-GEOD-18858

Units of amount
studied in E-GEOD-18858

Units of amount of vehicle
studied in E-GEOD-18858

vehicle for chemical
studied in E-GEOD-18858

Processing time: 0.166 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM